Sharp to Begin Mass-Production of Thin-Film Photovoltaic Modules

Jul 08, 2005

Sharp Corporation will introduce a new mass-production system for thin-film photovoltaic modules at its Katsuragi Plant in Nara Prefecture, and will begin operation in September of this year.

Compared to crystalline silicon photovoltaic modules, thin-film solar cell (photovoltaic) modules can be manufactured using a tiny amount of silicon, and in addition, can be used in application products that offer attractive design features such as “illuminating solar panels (Lumiwall)” where they are combined with LEDs, and see-through type solar panels that permit natural light to pass through.

In the midst of skyrocketing demand for solar cells, Sharp is aiming to further expand the range of applications, and has advanced the idea of thin-film photovoltaic modules that use crystalline thin-film tandem cells. This cell design is based a proprietary architecture that integrates amorphous silicon technology with crystalline thin-film silicon technology to boost conversion efficiency by 50% compared to existing solar cells. But demand for building materials in industrial fields is increasing, and at this time, Sharp has decided to proceed with full-scale construction of a production system with an annual capacity of 15 MW.

In the future, Sharp anticipates significant growth in demand for solar cells, and will be actively working to open up new areas of demand. In addition to currently available single-crystal and polycrystalline silicon solar cells, Sharp intends to strengthen “thin-film” type solar cells as a second pillar of our product line, and by developing such diverse line-up, will work to achieve its corporate vision of becoming a “Zero Global Warming Impact Company.”

Explore further: Festo has BionicANTs communicating by the rules for tasks

add to favorites email to friend print save as pdf

Related Stories

Gold nanoparticles for targeted cancer treatment

5 minutes ago

The use of tiny drug-loaded nanocarriers for the safe, targeted delivery of drugs to designated parts of the body has received much press in recent years. Human trials of nanocarriers targeting pancreatic ...

Recommended for you

Festo has BionicANTs communicating by the rules for tasks

3 hours ago

Germany-based automation company Festo, focused on technologies for tasks, turns to nature for inspiration, trying to take the cues from how nature performs tasks so efficiently. "Whether it's energy efficiency, ...

Jury decides Silicon Valley firm did not discriminate

3 hours ago

A jury decided Friday that a prestigious venture capital firm did not discriminate or retaliate against a female employee in a case that shined a light on gender imbalance and working conditions for women ...

Intel in talks with Altera on tie-up

3 hours ago

US tech giant Intel is in talks with rival Altera on a tie-up to broaden the chipmaker's product line amid growth in Internet-connected devices, the Wall Street Journal reported Friday.

Amazon says FAA drone approval already obsolete

6 hours ago

The approval federal aviation officials gave Amazon.com last week to test a specific drone design outdoors is already outdated, the company's top policy executive said Tuesday in written testimony to a Senate subcommittee.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.